Tactile Medical: Forged Orders and a False Case for the Costlier Device

The Tactile Medical 2026 compression device settlement required Tactile Systems Technology to pay $550,959 to resolve False Claims Act allegations over false treatment records, forged clinician signatures and Medicare claims for medically unnecessary devices. In the settlement agreement, Tactile admitted that certain sales personnel changed the records they were supposed to collect. Those changes made earlier treatment appear to have failed and made clinicians appear to have ordered devices. Whistleblowers brought the claims in two qui tam cases.

Tactile markets at-home pneumatic compression devices for patients with chronic swelling caused by lymphedema and chronic venous insufficiency. Its basic device is Entre. Its more expensive, advanced device is Flexitouch. The Justice Department announced the settlement on July 14, 2026, covering conduct from January 1, 2019 through December 31, 2024.

What Medicare Required Before Paying for a Compression Device

During the covered period, Medicare required a patient to have failed to obtain adequate relief after four weeks of conservative therapy, including basic compression. The prescribing health care professional had to explain in the medical record why basic compression had been inadequate.

That requirement made the treatment record part of the payment decision. A statement that earlier therapy had failed supplied a reason for Medicare to cover a pneumatic compression device. A clinician’s order supplied the prescription. Tactile required its sales personnel to collect and retain the documentation supporting its claims.

Tactile’s sales personnel marketed the devices to vascular surgeons, cardiologists, certified lymphedema therapists and other healthcare professionals treating these conditions. The same sales operation that promoted the equipment collected the clinical support for payment.

From Collected Records to Forged Orders

Tactile admitted that certain sales personnel fabricated or amended clinicians’ medical records and other clinical documentation. Some inserted false statements that patients had failed to obtain relief through basic compression therapy. The admitted conduct also included forging clinicians’ signatures on doctored records to make it appear that the clinicians had prescribed Entre or Flexitouch.

Those changes reached both parts of the coverage story: what had happened to the patient and what the clinician had decided. A false treatment history made the patient appear to need a device. A forged signature made a sales-created record look like a clinician’s order.

The company’s admission then follows the paperwork into the claim:

The people assigned to obtain the evidence of medical need were, in these instances, manufacturing it. Medicare was asked to pay for devices on the strength of treatment histories and prescriptions that sales staff had falsified.

A False Entre Failure Made Flexitouch Look Necessary

Tactile also admitted that certain sales personnel falsified records to say patients had not obtained sufficient swelling reduction with Entre and had benefited more from a trial of Flexitouch. This gave the more expensive device an apparent clinical justification.

Entre uses sequential inflation to move lymph fluid and blood from the limbs toward the torso. Flexitouch is designed to mimic the manual lymphatic drainage therapists perform in clinical settings. The products occupied different places in the treatment account, and the false records used that distinction to support the costlier one.

The admitted alteration went beyond adding a signature. It changed the reported result of using the basic device and the reported benefit of trying the advanced device. For someone who knows the treatment history, that is a concrete discrepancy: the clinical record says a comparison happened and produced a particular result. The question is who supplied that account and whether it matches what happened with the patient.

What Tactile Did After Discovering the Alterations

Tactile’s compliance department investigated sales personnel during the covered period and discovered the fabricated or amended records. The agreement says the company disciplined or terminated those personnel and voluntarily repaid Medicare for certain claims it considered medically unnecessary. The announcement says many of the sales personnel involved were terminated.

Supplier-Written Evaluations in the Numotion Case

Numotion’s wheelchair-evaluation settlement concerned a similar problem with who created the clinical support. The government alleged that supplier employees authored, completed or signed patient evaluations that required qualified medical professionals.

The common thread is who wrote the clinical judgment. In Numotion, the allegation concerned supplier employees creating evaluations reserved for qualified professionals. In Tactile’s agreement, the company admitted false treatment histories and forged signatures on records supporting its devices. Both accounts put the supplier’s involvement in the clinical paperwork at the center of the payment question.

What Kind of Proof Is Needed to Be a Whistleblower?

In a case like Tactile’s, the evidence is in the gap between what happened to the patient and what the supplier told Medicare. We help you connect the treatment history, the clinician’s documentation and the claim. The admissions identify the specific differences that matter: a treatment failure inserted into a record, a signature made to appear genuine, or an account of an Entre trial changed to favor Flexitouch.

Someone in sales may know who changed a document. Someone in the clinical practice may know what the prescriber actually ordered. Someone in reimbursement may know which version supported the claim. Those are different views of the same transaction, and we work with you to connect what you know to the claim it supported.

The compliance response adds another part of the account: when the company learned of the alterations, which claims it identified and what it repaid. Tactile’s admissions connect those internal decisions to the same records and devices. An insider who saw the document before and after a change may explain a discrepancy that the finished claim alone would conceal.

How Much Does a Medicare Fraud Whistleblower Get Paid?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Tactile’s settlement provided a collective share of the proceeds for the whistleblowers who brought the cases.

You Know Who Changed the Record

If you saw treatment histories rewritten or signatures added to support a compression-device claim, speak to one of our Whistleblower Experts about how those records were changed. We build your strongest case around the records and decisions you know, bring in medical device fraud whistleblower lawyers who understand Medicare coverage, and stay beside you through the case.